Mariya M. Kaganova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariya M. Kaganova has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Igor P. Shilovskiy
National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia
13 shared publications - Musa Rakhimovich Khaitov
National Research Center Institute of Immunology FMBA of Russia Moscow Russian Federation
13 shared publications - Aleksandr A. Nikolskii
Allergy and Immunology Research Centre, FMBA of Russia, Moscow
12 shared publications - E. D. Timotievich
National Research Center – Institute of Immunology of the Federal Medical-Biological Agency, Moscow
12 shared publications - Kirill V. Yumashev
Allergy and Immunology Research Centre, FMBA of Russia, Moscow
11 shared publications - Valeriia I. Kovchina
NRC Institute of immunology FMBA of Russia, 115522 Moscow, Russia
11 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 46 (5)
Silensing of the Il33 gene expression using synthetic siRNA molecules leads to a decrease in nasal hyperreactivity and inflammation of the nasal mucosa in a mouse model of allergic rhinitis
Снижение активности гена Il33 с использованием синтетических молекул миРНК приводит к уменьшению назальной гиперреактивности и воспаления слизистой
- 1 January 2025
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 46 (5)
Open AccessSilensing of the Il33 gene expression using synthetic siRNA molecules leads to a decrease in nasal hyperreactivity and inflammation of the nasal mucosa in a mouse model of allergic rhinitis
Снижение активности гена Il33 с использованием синтетических молекул миРНК приводит к уменьшению назальной гиперреактивности и воспаления слизистой
- Open Access
- 23 April 2024
- Published by Agrarian Science in Agrarian science
- No. 4,p. 24-28
Antiproliferative activity in vitro of Trichinella spiralis larval extracts depending on the infection stage following experimental infection of rats
Relevance.The aim is evaluation in vitro antiproliferative activity of T. spiralis larvae extracts obtained from experimentally infected rats, depending on the duration of infection.Methods. The experiment was carried out on outbred male rats infected with T. spiralis larvae at the rate of 10 larvae per 1 g of body weight. The antiproliferative activity of larval extracts obtained 40 days, 3 and 12 months after infection was determined on tumor cells of the A549 line (human lung carcinoma) using an MTT test during cultivation for 24, 48 and 72 hours in concentrations from 32 to 1000 micrograms/ml. Antiproliferative activity was expressed as % inhibition and IC50.Results. There was direct dependence of Trichinella extract antiproliferative effects on time of cultivation with A549 cells and protein concentration in extracts. At all stages of invasion, the antiproliferative activity of the extract increased from 24 to 72 hours. at a protein concentration of 250 to 1000 mcg/ml. The extract antiproliferative activity expressed in tumor cell % inhibition and IC50 increased from day 40 to month 12. The most intense dynamics was observed between day 40 and month 3. The possible reason of enhancement in extract antiproliferative effect at months 3 and 12 is alteration in quantitative and qualitative composition of proteins comprised the extracts.
- 23 April 2024
- Published by Agrarian Science in Agrarian science
- No. 4,p. 24-28
Open AccessAntiproliferative activity in vitro of Trichinella spiralis larval extracts depending on the infection stage following experimental infection of rats
Relevance.The aim is evaluation in vitro antiproliferative activity of T. spiralis larvae extracts obtained from experimentally infected rats, depending on the duration of infection.Methods. The experiment was carried out on outbred male rats infected with T. spiralis larvae at the rate of 10 larvae per 1 g of body weight. The antiproliferative activity of larval extracts obtained 40 days, 3 and 12 months after infection was determined on tumor cells of the A549 line (human lung carcinoma) using an MTT test during cultivation for 24, 48 and 72 hours in concentrations from 32 to 1000 micrograms/ml. Antiproliferative activity was expressed as % inhibition and IC50.Results. There was direct dependence of Trichinella extract antiproliferative effects on time of cultivation with A549 cells and protein concentration in extracts. At all stages of invasion, the antiproliferative activity of the extract increased from 24 to 72 hours. at a protein concentration of 250 to 1000 mcg/ml. The extract antiproliferative activity expressed in tumor cell % inhibition and IC50 increased from day 40 to month 12. The most intense dynamics was observed between day 40 and month 3. The possible reason of enhancement in extract antiproliferative effect at months 3 and 12 is alteration in quantitative and qualitative composition of proteins comprised the extracts.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (6)
The effect of interleukin-37 on the process of NETosis in human neutrophils in vitro
Влияние интерлейкина-37 на процесс НЕТоза у нейтрофилов человека in vitro
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (6)
Open AccessThe effect of interleukin-37 on the process of NETosis in human neutrophils in vitro
Влияние интерлейкина-37 на процесс НЕТоза у нейтрофилов человека in vitro
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (2)
The role of the triad of respiratory epithelial cell-derived cytokines in the pathogenesis of allergic rhinitis
Роль триады цитокинов, продуцируемых респираторным эпителием, в патогенезе аллергического ринита
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (2)
Open AccessThe role of the triad of respiratory epithelial cell-derived cytokines in the pathogenesis of allergic rhinitis
Роль триады цитокинов, продуцируемых респираторным эпителием, в патогенезе аллергического ринита
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (1)
Synthetic small interfering RNAs targeted to conservative region of the rhinovirus genome suppress the infection in vitro
Синтетические молекулы малых интерферирующих РНК против консервативного участка генома риновируса подавляют инфекцию in vitro
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (1)
Open AccessSynthetic small interfering RNAs targeted to conservative region of the rhinovirus genome suppress the infection in vitro
Синтетические молекулы малых интерферирующих РНК против консервативного участка генома риновируса подавляют инфекцию in vitro
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (5)
Synthetic siRNA molecules suppress Il4 and Il13 gene expression and reduce allergic inflammation and remodeling of upper airways in mouse model
Синтетические молекулы миРНК подавляют экспрессию генов Il4 и Il13 и уменьшают аллергическое воспаление и ремоделирование верхних дыхательных путей в
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (5)
Open AccessSynthetic siRNA molecules suppress Il4 and Il13 gene expression and reduce allergic inflammation and remodeling of upper airways in mouse model
Синтетические молекулы миРНК подавляют экспрессию генов Il4 и Il13 и уменьшают аллергическое воспаление и ремоделирование верхних дыхательных путей в
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (5)
Suppression of respiratory syncytial virus infection in vitro by small interfering RNAs complexed with bifunctional peptide carrier
Подавление репликации респираторно-синцитиального вируса in vitro комплексом молекул малых интерферирующих РНК и бифункционального пептида-носителя
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (5)
Open AccessSuppression of respiratory syncytial virus infection in vitro by small interfering RNAs complexed with bifunctional peptide carrier
Подавление репликации респираторно-синцитиального вируса in vitro комплексом молекул малых интерферирующих РНК и бифункционального пептида-носителя
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (2)
A synthetic peptide mimicking the antigenic site of F protein suppresses of respiratory syncytial virus infection in vitro
Синтетический пептид, имитирующий антигенный сайт белка F, подавляет инфекцию респираторно-синцитиального вируса в экспериментах in vitro
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (2)
A synthetic peptide mimicking the antigenic site of F protein suppresses of respiratory syncytial virus infection in vitro
Синтетический пептид, имитирующий антигенный сайт белка F, подавляет инфекцию респираторно-синцитиального вируса в экспериментах in vitro